We investigated whether the intermediate filament protein and neural stem cell marker nestin characterizes the glomerular progenitor/reserve cell population immigrating the glomerulus after mesangial cell (MC) injury in the rat (anti-Thy1 nephritis). Nestin expression was investigated by immunohistochemistry and real-time PCR during anti-Thy1 nephritis. Migration and proliferation assays were used to characterize the function of nestin in isolated MCs after nestin knockdown by siRNA. After MC injury during anti-Thy1 nephritis, glomerular nestin was transiently increased during the repopulation phase. At the peak of mesangial proliferation and expansion (day 5) most OX-7-positive MCs expressed nestin largely colocalizing with the activation marker α-smooth muscle actin and the proliferation marker PCNA. In contrast to a healthy, non-injured mesangium in vivo, MCs in culture are considered to be in an ‘activated, injured state’ and express nestin in a generalized distribution with condensed localization around the nucleus as well as intensive staining of cell protrusions such as filopodia. During cell cycle, the percentage of MCs with high nestin levels was increased during S- aupnd G2-phase. Blocking of nestin using specific siRNA resulted in inhibition of cell proliferation but not cell migration. In conclusion, nestin is constitutively expressed in podocytes, but is a marker for repopulating MCs after experimental MC injury in vivo. Nestin promotes MC proliferation in vitro, suggesting a supporting role for nestin during repair reaction.
Nestin is a class VI intermediate filament protein originally described as a marker for neuroepithelial stem cells.1 Later on, nestin was also described in non-neural progenitor and stem cells, such as the pancreatic islet2, 3, 4, 5 as well as hematopoietic6 or hair follicle sheath progenitor populations,7, 8 suggesting that its presence in cells may indicate multi-potentiality and regenerative potential.9
Nestin is also expressed during developmental processes such as myogenesis of skeletal muscle and heart or the developing tooth bud,10 or the developing eye.11 Upon differentiation, nestin is downregulated,12, 13 but reappears transiently after injury to muscle,14 brain15, 16 and liver.17 In the kidney, nestin is also expressed during development,18, 19 but its expression persists in the podocytes of mature glomeruli.18, 20 After podocytic injury, nestin is found to be upregulated within podocytes.20
In the anti-Thy1 nephritis model, the intraglomerular mesangium is destroyed by an antibody-mediated reaction followed by repair via migrating and proliferating mesangial ‘reserve’ cells.21 More than 90% of these repopulating cells originate from the extraglomerular or hilar mesangium, whereas less than 10% of the repopulating cells may be derived from the bone marrow,21, 22 supporting the concept of a predominantly locally regulated repair process similar to experimental ischemic tubulointerstitial injury of the kidney.23 Nevertheless, detailed characterization of these repopulating glomerular cells as well as markers to identify renal stem cells/progenitor cells are still lacking.24 Repair of the injured glomerulus requires both cell migration and cell proliferation.
This study was undertaken to characterize the expression of the stem cell marker nestin during mesangial cell (MC) repopulation and to investigate nestins role in MC migration and proliferation.
MATERIALS AND METHODS
Mesangial proliferative glomerulonephritis (anti-Thy1 model)
The animal studies were performed in accordance with the Internal Animal Review Board (Regierung von Mittelfranken: 621-2531.31-04/03). Experimental mesangial proliferative glomerulonephritis was induced in six Sprague–Dawley rats (150–200 g; Charles River, Sulzfeld, Germany) by a single injection of 1 mg/kg of the mouse monoclonal anti-Thy1 antibody OX-7 (purified from supernatant of OX-7 hybridoma cells (purchased from the European Collection of Animal Cell Cultures, Porton Down, Salisbury, UK)). Renal biopsies, as described previously,21 were performed on days 3 and 5, and the experiment was finished on day 8. Additionally, biopsies of a group from six healthy controls were taken to investigate constitutive nestin expression in the kidney. To evaluate nestin mRNA during anti-Thy1 nephritis, we performed a second independent experiment using four rats each for glomerular preparations from anti-Thy1 nephritic kidneys 0, 1, 3, 5 and 8 days after induction of the disease. Glomerular preparations were done by the standard sieving procedure as described previously.25
Biopsies from healthy human and mouse kidneys
Normal human renal tissue (n=6) was obtained from kidneys surgically excised because of the presence of a localized neoplasm. Tissues utilized for this study were obtained from macroscopically normal portions of kidney located at some distance from the neoplastic process. Kidneys used in this study were obtained from the Department of Pathology at the University Erlangen-Nuremberg (Erlangen, Germany). Kidney biopsies from healthy mice were obtained from six male C57bl6 mice with a body weight of 20–25 g.
Immunohistochemistry of renal biopsies and cultured glomerular cells
Renal biopsies from mice and rats were fixed in methyl Carnoy's solution and human biopsies in formalin. Tissues were embedded in paraffin and cut into 3-μm sections for indirect immunoperoxidase staining or immunofluorescence as described elsewhere.21, 26
The following antibodies were used in this study: nestin, clone rat 401 a murine IgG1 mAb specific for rat and murine nestin (Chemicon International, Temecula, CA, USA); nestin, clone 4D4 a murine IgG1 mAB specific for murine nestin (Biotrend, Köln, Germany); nestin, a murine IgG1 mAb specific for human nestin (Chemicon); OX-7, a murine IgG1 mAb specific for rat CD90 expressed on MCs (Serotec Ltd, Oxford, UK);21 α-smooth muscle actin (α-sm-actin), a murine IgG2 mAb specific for activated MCs (Dako, Hamburg, Germany);27 RECA-1, a murine IgG mAb specific for rat endothelial cells (Serotec Ltd);28, 29 ezrin, a murine IgG1 mAb specific for ezrin (Labvision Corporation, Fremont, CA, USA); and26 proliferating-cell nuclear antigen (PCNA), a murine IgG1 mAb (clone PC10) specific for the PCNA (Dako, Glostrup, Denmark). Negative controls for immunostaining included either deleting the primary antibody or substitution of the primary antibody with equivalent concentrations of an irrelevant murine monoclonal antibody or preimmune rabbit/goat IgG.
To determine glomerular nestin in Thy-1 nephritic kidneys in each biopsy, 40 cortical glomerular cross-sections were evaluated by computerized morphometry (Visitron Systems GmbH, Puchheim, Germany) in a blinded manner.
Immunohistochemical double stainings
To determine the number of nestin-positive proliferating cells in nephritic kidneys, double immunostaining for PCNA, a marker for cell proliferation, and nestin was performed as described previously.25 As secondary antibody, we used a rat adsorbed biotinylated horse anti-mouse IgG (Vector, Burlingame, USA), which was detected by horseradish peroxidase-conjugated avidin D (Vector). The peroxidase substrate 3,3′-diaminobenzidine (substrate kit; Vector) was used without nickel resulting in a brown staining (nestin) and Histogreen (Vector) was used for green nuclear staining (PCNA).
For colocalization studies, the anti-nestin antibody was directly labeled with the fluorochrome Alexa 488 using the Zenon mouse IgG labeling Kit (Molecular Probes Europe, Leiden, The Netherlands) following the manufacturer's instructions. Cell-specific markers (ezrin, Ox-7, RECA) or activation marker (sm-actin) were detected using a highly cross-absorbed donkey anti-mouse IgG antibody conjugated with Alexa 555 (Molecular Probes Europe).
Real-time quantitative RT-PCR
For evaluation of nestin mRNA levels during anti-Thy1 nephritis, RNA was purified from isolated glomeruli collected 0, 1, 3, 5 and 8 days after nephritis induction. Glomeruli were lysed in RLT buffer and RNA was purified using Rneasy micro-columns (both from Qiagen, Hilden, Germany), with subsequent DNAse digestion following the manufacturer's instructions. Reverse transcription was performed using reverse transcription reagents from ABgene, Hamburg, Germany, following the manufacturer's instructions.
Real-time RT-PCR was performed on a TaqMan® ABI 7000 Sequence detection system using the Mastermix (all ABgene). After an initial hold of 15 min at 95°C, samples were cycled 40 times at 95°C for 15 s and 60°C for 60 s. The cDNA content of each sample was compared with 18S as housekeeping gene following the ΔΔCt technique.30 Both genes were quantified using the SYBR-GREEN method. For nestin mRNA detection, we used the Rn_Nes_1_SG QuantiTect Primer Assay (Qiagen) and for the housekeeping 18S (forward primer 5′-TTGATTAAGTCCCTGCCCTTTGT; reverse primer 5′-CGATCCGAGGGCCTCACTA-3′).
Mouse MCs were cultured from isolated glomeruli using standard sieving procedure31 and characterized by positive staining for α-sm-actin and α8-integrin, and the lack of the epithelial marker WT-1, endothelial marker CD-31 and the macrophage/monocyte marker CD68. MCs were grown in DMEM containing 10% FCS, insulin (5 μg/ml) and penicillin/streptomycin at 37°C and 5% CO2.
Flow cytometry analysis
Nestin expression was analyzed by flow cytometry using a mouse anti-nestin antibody (Chemicon). For investigation of nestin's role during MC proliferation, we simultaneously stained for DNA using propidium iodide and nestin. First, nestin expression was investigated in growing, non-synchronized MCs. Second, for time-course experiments and analysis of proliferation, MCs were starved for 2 days in serum-deprived culture medium, followed by stimulation with either 10% FCS or 20 ng/ml platelet-derived growth factor (PDGF) for 0, 7, 15 and 24 h. MCs were fixed over night in ice-cold 65% methanol after detatchment of growing cells from petri dishes by trypsin treatment. After washing with PAB buffer (PBS containing 2% BSA and 0.01% sodium azide), cells were permeabilized with 0.1% Triton X-100 in PBS for 15 min at 37°C, followed by washing with PAB buffer. For staining of DNA, RNA was digested by RNAse A (1 mg/ml in PBS) for 12 min at 37°C, and for 40 min at room temperature. After washing with PAB buffer, cells were incubated with anti-nestin antibody (diluted 1:400 in PAB buffer for 2 h at 4°C), washed again with PAB buffer, followed by incubation with an FITC-conjugated rabbit anti-mouse IgG antibody (Dako). After removal of non-bound antibody, MCs were facultatively stained with propidium iodide (50 μg/ml in PBS) and analyzed by flow cytometry analysis (EPICX XL; Beckman-Coulter, Krefeld, Germany) using EXPO32 ADC software (Beckman-Coulter). Cells were defined as nestin-negative when a similar FACS signal was detected than in controls without primary antibody. DNA staining by propidium iodide was also used for cell-cycle analysis. Percentages of G1, S and G2 cell-cycle phase were analyzed using Multicycle software (Phoenix Flow Systems, San Diego, USA).
Transfection with nestin siRNA
Mouse MCs were transfected with two HP GenomeWide siRNAs against nestin, a negative-control siRNA, or transfection reagent alone all purchased by Qiagen. Cells were transfected with 1, 10 and 50 nM siRNA each using HiPerfect (Qiagen) as transfection reagent following the manufacturer's instructions. All tested nestin siRNA concentrations were able to downregulate nestin 48 h after transfection. Best specific effects without off-target effects were achieved using 10 nM siRNA. Consequently, experiments using 10 nM siRNA were shown. Downregulation of nestin was evaluated by flow cytometry analysis and cells were tested in proliferation and migration assays.
To exclude inhibition of cell-cycle proliferation due to toxicity of siRNA, we measured lactate dehydrogenase activity in the culture media of siRNA- vs non-treated MCs. Lactate dehydrogenase activity was analyzed using LDH cytotoxicity detection kit purchased from Takara Bio Inc. (Shiga, Japan) following the manufacturer's instructions. With the exception of nestin siRNA B, which induced some low cytotoxicity of about 10%, all other investigated samples did not express any cytotoxicity.
Proliferation of MCs treated either with nestin siRNA or control siRNA was monitored by bromodeoxyuridine (BrdU) uptake during S-phase using a cell proliferation ELISA (colorimetric) purchased from Roche Diagnostics GmbH, Mannheim, Germany, following the manufacturer's instructions. One thousand siRNA-transfected mouse MCs were seeded per well of a microtiter plate and starved for 2 days in culture medium supplemented with 0.1% FCS. Pulsing with BrdU was performed for 2 h a day after stimulation with 10% FCS. Proliferative cell activity of a representative experiment was shown. All assays were performed in sextuplicate and each experiment was performed a minimum of three times.
In vitro cell migration assay
MC migration was investigated using a Transwell 48-well modified Boyden chamber and 0.1% gelatine-coated polyvinyl-pyrrolidone-free polycarbonate membranes with 8-μm pore size (Neuroprobes Inc., Gaithersburg, MD, USA). Two days after transfection with siRNAs, 28 000 mouse MC per well were loaded into the upper chamber. The bottom wells were filled with 40 μg/ml fibronectin, used as the chemoattractant, or 0.1% BSA, used as a negative control. The Boyden chamber was incubated for 5 h at 37°C and 5% CO2 to allow migration of cells through the membrane. Cells that had transmigrated were stained with Qick diff and three fields of vision per well were analyzed using phase-contrast microscopy at a × 250 magnification. All assays were performed in triplicate and each experiment was performed a minimum of three times.
All values are expressed as mean±s.d. Statistical significance (defined as P<0.05) was evaluated with SPSS software (SPSS GmbH, Munich, Germany) using the Student's t-test and ANOVA .
In Healthy Kidneys, Nestin is Expressed by Podocytes of Mouse, Rat and Human Origin
Nestin expression was detected in adult kidney biopsies of three different species, including mouse, rat and human origin, using immunohistochemistry with three different nestin-specific antibodies. Glomeruli from all three species show specific nestin staining restricted to podocytes (Figure 1a–c), whereas resting MCs are devoid of nestin. Since this study was undertaken to characterize the expression of nestin during MC repopulation, we evaluated nestin during anti-Thy1 nephritis after severe MC injury.
Nestin is Transiently Expressed De Novo by Repopulating MCs During Glomerular Repair after Mesangial Injury
Few days after induction of anti-Thy1 nephritis, glomeruli start to regenerate the destroyed mesangium via repopulation by a coordinated migratory and proliferative response from the hilar region. On day 3 after disease induction, besides predominant nestin staining in podocytes (Figure 1d, P), repopulating glomerular cells in the hilar region (Figure 1d and h) are also positive for the intermediate filament protein nestin. De novo expression of nestin showing a typical mesangial pattern becomes more prominent during the mesangial proliferative phase of anti-Thy1 nephritis on day 5, demonstrating a nearly twofold total glomerular upregulation compared with healthy control rats (Figure 1e and g). In addition, podocytic nestin expression also appears to be elevated. The significant upregulation of nestin persists up to day 8 in nephritic glomeruli, but was slightly decreased compared with day 5 values (Figure 1f and g). Glomerular nestin mRNA as assessed by quantitative PCR reaches its maximum on day 3 during anti-Thy1 nephritis, with an upregulation of 2.31±0.77 fold compared with levels found in healthy controls (Figure 1h). Five days after disease induction, nestin mRNA decreases to 1.4±0.2 fold upregulation, decreasing further on day 8 to levels slightly lower than in healthy control glomeruli (Figure 1h).
To confirm mesangial expression of nestin during anti-Thy1 nephritis, we performed double stainings using cell-specific markers (Figure 2). Nestin colocalizes with immigrating Ox-7-positive MCs on day 3 (Figure 2a–c, arrows) and day 5 (Figure 2d–f), and with ezrin-positive podocytes (Figure 2g–i) 5 days after induction of anti-Thy1 nephritis. Since MCs are lacking nestin in the healthy kidney, further colocalization studies were performed to characterize the phenotype (activated, proliferative) of nestin-positive MCs. We found colocalization of nestin with α-sm-actin, a cytoskeletal marker for activated MCs, in most but not all areas on day 5 of anti-Thy1 nephritis (Figure 2j–l). In contrast, staining for the endothelial marker RECA-1 is clearly separated from nestin-positive cells (Figure 2m–o) during anti-Thy1 nephritis.
Nestin is Expressed in MCs Under In Vitro Conditions
Nestin positivity in cultured MCs is consistent with an indication of activation/phenotypic change, since cultured MCs in contrast to a healthy, non-injured mesangium in vivo, are considered to be in an ‘activated, injured state’ (Figure 3a and d). Cultured MCs show a generalized nestin distribution with condensed localization around the nucleus as well as marked staining of cell protrusions such as filopodia (Figure 3d). In actively spreading MCs, nestin was found within lamellipodia colocalizing with vinculin (Figure 3a–c). Nestin expression was increased in dividing cells (Figure 3a and e, d) compared with that in non-dividing cells (Figure 3a and e, nd), but remained at the same expression level within the filopodia.
PDGF and FCS Induced Nestin Expression in MCs In Vitro
In MCs growth-arrested by serum deprivation, we found 10–20% cells to be negative for nestin (Figure 4a and b), and less than 10% highly positive for nestin (Figure 4a and b; Table 1). Nestin was significantly upregulated by both FCS and PDGF stimulation (Figure 4; Table 1). Stimulation with PDGF induced significantly higher nestin expression in MCs starting after 7 h and reaching its maximum with 3.5-fold increased levels of highly nestin positive cells at 24 h (Figure 4a, c, e and g; Table 1). Similar induction of nestin expression was observed after stimulation with 10% FCS, reaching significance 15 h after induction (Figure 4b, d and f; Table 1). Both stimuli increased nestin expression before significant changes in cell cycle could be detected (Table 1). Statistically significant changes in the distribution of cell-cycle stages were found not before 24 h after the proliferative stimulus by FCS or PDGF (Table 1).
Nestin is Differentially Expressed During Cell Cycle and Promotes Cell Proliferation
Double staining of nestin during anti-Thy1 nephritis with the proliferation marker PCNA revealed that nestin-positive MCs are highly proliferative. On day 3 after nephritis induction when the mesangial repopulation process starts, as well as later on day 5 at the peak of repair, repopulating cells are predominantly nestin/PCNA double positive (Figure 5a and b, arrows).
To determine whether de novo expression of nestin by MCs is involved in MC proliferation, we investigated nestin expression during cell cycle of MCs and cell proliferation after blocking of nestin expression by siRNA transfection.
In vitro experiments with double staining for DNA and nestin showed that nestin was differentially expressed during cell cycle of non-synchronized cultured MCs (Figure 5d). This differential nestin expression was similar in synchronized MCs treated with either transfection reagent only or a negative-control siRNA (Figure 5f). During S-phase, the percentage of MCs with high nestin levels was nearly doubled and was 2.5-fold higher during G2-phase compared with cells of the G1-phase (Figure 5d, black bars; Figure 5f, white bars). Two different siRNA sequences clearly downregulated nestin expression in MCs 48 h after transfection compared with cells treated with control siRNA (Figure 5e and f). The extent of nestin inhibition by siRNA was similar during all cell cycle stages, producing five times less cells highly positive for nestin compared with negative controls (Figure 5f). The influence of nestin on cell proliferation was investigated by BrdU incubation as well as cell-cycle analysis. Nestin siRNA significantly and reproducibly inhibited MC proliferation by 10–18%, depending on the effectivity of the siRNA block (Figure 5e and g). Consequently, the percentage of MCs in G1-phase was significantly higher and in S-phase significantly lower (Figure 5h).
Downregulation of Nestin did not Affect MC Migration
Since MCs immigrating during repopulation are both proliferating and migrating, we also investigated the consequences of nestin blocking using a Transwell migration assay. Forty-eight hours after siRNA transfection, two nestin-specific siRNAs did not change MC migration compared with MCs treated with control siRNA or transfection reagent only (Figure 6).
Nestin is an intermediate filament protein and a marker for neuroepithelial and non-neural stem cells,1 suggesting that its presence in cells may indicate multi-potentiality and regenerative potential.9 In this study, we examined whether nestin could be a marker for repopulating mesangial precursor/reserve cells after injury in the anti-Thy1 model in the rat.
The first major finding in this study is that nestin, besides its constitutive podocytic expression, is de novo expressed by repopulating MCs after injury. After severe mesangiolysis, most of the destroyed mesangium is replaced within days by migrating and proliferating Ox-7-positive MCs originating from the hilar and extraglomerular mesangium, restoring the glomerular architecture in a coordinated manner from the hilus toward the glomerular periphery.21 Here, timely repair of the injured glomerular endothelium appears to be required for successful healing reaction of the glomerular architecture,32 and may indicate the importance of endothelial–mesangial interaction for this repair process. While these immigrating glomerular cells express the typical mesangial marker protein Ox-7, most of them are also positive for α-sm-actin, indicating a different or ‘activated’ phenotype compared with normal healthy MCs that are α-sm-actin negative.27 Coexpression of nestin with the activation marker α-sm-actin was recently reported in myofibroblasts after induction of obstructive nephropathy,33 suggesting a role of nestin in cells with an ‘activated’ phenotype. It is a matter of debate whether these immigrating cells are normal MCs acquiring a transient phenotype switch during repair, or whether they are primarily different from normal MCs and differentiate into MCs by loosing their specific phenotypical characteristics (α-sm-actin positivity etc.) once they are incorporated in the glomerular architecture. While this study was not designed to answer the latter question, transient nestin positivity of these immigrating cells suggests involvement in cell migration and multi-potentiality. As reported for glia cells,34 we found that stimulation with PDGF also resulted in upregulation of nestin in cultured MCs. Since the major proproliferative cytokine PDGF is known to be upregulated in MCs during anti-Thy1 nephritis,35 this is a potential mechanism for nestin induction in this mesangioproliferative model. We found coexpression of nestin with the proliferation marker PCNA in most glomerular areas during anti-Thy1 nephritis, suggesting that nestin is potentially involved in cell proliferation.
The second major finding of this study indicates that nestin is not just upregulated in repopulating and proliferating MCs, but also has a function in MC proliferation but not in migration. Earlier studies described nestin as a marker of highly proliferative36, 37, 38, 39 and migrating cells.37 In the kidney, a recent study showed nestin-positive cells migrating from the renal papilla to the cortex after ischemia/reperfusion,40 indicating a potential role of nestin also for renal cell migration. We found that nestin is a marker that promotes MC proliferation but not migration in vitro. In this study, blocking of nestin resulted in mild but significant and consistent inhibition of MC proliferation, indicating that nestin promotes MC proliferation, but is not essential for this process. Since blocking of nestin in MCs by siRNA was not complete, the relevance of nestin on MC proliferation may even be more important than seen in our studies. The mechanisms and involvement of nestin in cell proliferation and migration are not completely understood. Nestin preferentially forms intermediate filaments by assembly with other intermediate filament proteins like vimentin and desmin,41 contributing to mechanical stability of cells.20 Vimentin and desmin are both found to be upregulated in MCs during anti-Thy1 nephritis.27 Nestin is furthermore suggested to act as a linker or cross-bridge protein between intermediate filaments, microfilaments and microtubules.42, 43 In rapidly dividing and migrating cells assembly and disassembly of filaments need to be strictly regulated. In a neuronal stem cell line, nestin was found to be reorganized during mitosis in.44 Phosphorylation of nestin by different kinases leads to disassembly of nestin filaments during mitosis44 or development of neuronal precursor cells.45
This role of nestin during MC proliferation is further supported by the additional findings that nestin expression is clearly regulated during cell-cycle progression and that nestin knockdown by siRNA does affect cell-cycle progression in cultured MCs. In cultured MCs, nestin is markedly increased around nuclei of dividing cells and is strongly upregulated during S- and G2-phases compared with S1-phase. One potential mechanism of nestin-mediated cell-cycle progression is its role in regulation of vimentin. Disassembly of vimentin by nestin becomes further important, since disassembled, non-filamentous vimentin was able to move protein particles at high speeds along microtubles with molecular motors.10 Here, rapid transport of precursor molecules between different cytplasmatic compartments may allow nestin-positive cells to divide more rapidly.10 Differential expression of nestin during cell cycle suggests that nestin's function can be regulated by phosphorylation and upregulation of its expression. In other cell types, nestin's involvement was found in both cell proliferation and migration. In contrast to the results in this study, blocking of nestin by antisense expressing plasmids in human neuroblastoma cells resulted in reduction of cell motility by more than 40% in vitro,46 suggesting that involvement of nestin in cell migration is dependent on the cell type. Furthermore, blocking of nestin in cultured podocytes prevents the formation of foot processes,18 suggesting a role for nestin in organization of the cytoskeleton.
In conclusion, whereas podocytes demonstrate constitutive nestin expression in normal healthy glomeruli, diseased glomeruli specifically express nestin de novo in repopulating MCs. Our studies in vitro suggest that nestin is a marker for repopulating cells, which promotes MC proliferation but not migration.
Lendahl U, Zimmerman LB, McKay RD . CNS stem cells express a new class of intermediate filament protein. Cell 1990;60:585–595.
Hunziker E, Stein M . Nestin-expressing cells in the pancreatic islets of Langerhans. Biochem Biophys Res Commun 2000;271:116–119.
Zulewski H, Abraham EJ, Gerlach MJ, et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 2001;50:521–533.
Lechner A, Leech CA, Abraham EJ, et al. Nestin-positive progenitor cells derived from adult human pancreatic islets of Langerhans contain side population (SP) cells defined by expression of the ABCG2 (BCRP1) ATP-binding cassette transporter. Biochem Biophys Res Commun 2002;293:670–674.
Abraham EJ, Kodama S, Lin JC, et al. Human pancreatic islet-derived progenitor cell engraftment in immunocompetent mice. Am J Pathol 2004;164:817–830.
Walczak P, Chen N, Hudson JE, et al. Do hematopoietic cells exposed to a neurogenic environment mimic properties of endogenous neural precursors? J Neurosci Res 2004;76:244–254.
Li L, Mignone J, Yang M, et al. Nestin expression in hair follicle sheath progenitor cells. Proc Natl Acad Sci USA 2003;100:9958–9961.
Hoffman RM . The pluripotency of hair follicle stem cells. Cancer Biol Ther 2006;5:232–233.
Wiese C, Rolletschek A, Kania G, et al. Nestin expression—a property of multi-lineage progenitor cells? Cell Mol Life Sci 2004;61:2510–2522.
Michalczyk K, Ziman M . Nestin structure and predicted function in cellular cytoskeletal organisation. Histol Histopathol 2005;20:665–671.
Yang J, Bian W, Gao X, et al. Nestin expression during mouse eye and lens development. Mech Dev 2000;94:287–291.
Zimmerman L, Parr B, Lendahl U, et al. Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron 1994;12:11–24.
Lothian C, Lendahl U . An evolutionarily conserved region in the second intron of the human nestin gene directs gene expression to CNS progenitor cells and to early neural crest cells. Eur J Neurosci 1997;9:452–462.
Vaittinen S, Lukka R, Sahlgren C, et al. The expression of intermediate filament protein nestin as related to vimentin and desmin in regenerating skeletal muscle. J Neuropathol Exp Neurol 2001;60:588–597.
Krum JM, Rosenstein JM . Transient coexpression of nestin, GFAP, and vascular endothelial growth factor in mature reactive astroglia following neural grafting or brain wounds. Exp Neurol 1999;160:348–360.
Duggal N, Schmidt-Kastner R, Hakim AM . Nestin expression in reactive astrocytes following focal cerebral ischemia in rats. Brain Res 1997;768:1–9.
Gleiberman AS, Encinas JM, Mignone JL, et al. Expression of nestin-green fluorescent protein transgene marks oval cells in the adult liver. Dev Dyn 2005;234:413–421.
Chen J, Boyle S, Zhao M, et al. Differential expression of the intermediate filament protein nestin during renal development and its localization in adult podocytes. J Am Soc Nephrol 2006;17:1283–1291.
Wagner N, Wagner KD, Scholz H, et al. The intermediate filament protein nestin is expressed in the developing kidney and heart and might be regulated by the Wilms' tumor suppressor Wt1. Am J Physiol Regul Integr Comp Physiol 2006;291:R779–R787.
Zou J, Yaoita E, Watanabe Y, et al. Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury. Virchows Arch 2006;448:485–492.
Hugo C, Shankland SJ, Bowen-Pope DF, et al. Extraglomerular origin of the mesangial cell after injury. A new role of the juxtaglomerular apparatus. J Clin Invest 1997;100:786–794.
Ito T, Suzuki A, Imai E, et al. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol 2001;12:2625–2635.
Lin F, Moran A, Igarashi P . Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 2005;115:1756–1764.
Lin F, Igarashi P . Searching for stem/progenitor cells in the adult mouse kidney. J Am Soc Nephrol 2003;14:3290–3292.
Hugo C, Pichler R, Meek R, et al. Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. Kidney Int 1995;48:1846–1856.
Hugo C, Nangaku M, Shankland SJ, et al. The plasma membrane-actin linking protein, ezrin, is a glomerular epithelial cell marker in glomerulogenesis, in the adult kidney and in glomerular injury. Kidney Int 1998;54:1934–1944.
Johnson RJ, Iida H, Alpers CE, et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 1991;87:847–858.
Kang DH, Kanellis J, Hugo C, et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 2002;13:806–816.
Iruela-Arispe L, Gordon K, Hugo C, et al. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol 1995;147:1715–1727.
Dimmler A, Haas CS, Cho S, et al. Laser capture microdissection and real-time PCR for analysis of glomerular endothelin-1 gene expression in mesangiolysis of rat anti-Thy 1.1 and murine Habu Snake Venom glomerulonephritis. Diagn Mol Pathol 2003;12:108–117.
Johnson RJ, Garcia RL, Pritzl P, et al. Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 1990;136:369–374.
Daniel C, Renders L, Amann K, et al. Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat. Am J Transplant 2005;5:2849–2861.
Sakairi T, Hiromura K, Yamashita S, et al. Nestin expression in the kidney with an obstructed ureter. Kidney Int 2007;72:307–318.
Gallo V, Armstrong RC . Developmental and growth factor-induced regulation of nestin in oligodendrocyte lineage cells. J Neurosci 1995;15 (1 Pt 1):394–406.
Ostendorf T, Kunter U, van Roeyen C, et al. The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system. J Am Soc Nephrol 2002;13:658–667.
Namiki J, Tator CH . Cell proliferation and nestin expression in the ependyma of the adult rat spinal cord after injury. J Neuropathol Exp Neurol 1999;58:489–498.
Mothe AJ, Tator CH . Proliferation, migration, and differentiation of endogenous ependymal region stem/progenitor cells following minimal spinal cord injury in the adult rat. Neuroscience 2005;131:177–187.
Rice AC, Khaldi A, Harvey HB, et al. Proliferation and neuronal differentiation of mitotically active cells following traumatic brain injury. Exp Neurol 2003;183:406–417.
Chouaf-Lakhdar L, Fevre-Montange M, Brisson C, et al. Proliferative activity and nestin expression in periventricular cells of the adult rat brain. Neuroreport 2003;14:633–636.
Patschan D, Michurina T, Shi HK, et al. Normal distribution and medullary-to-cortical shift of nestin-expressing cells in acute renal ischemia. Kidney Int 2007;71:744–754.
Herrmann H, Aebi U . Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr Opin Cell Biol 2000;12:79–90.
Hirokawa N, Glicksman MA, Willard MB . Organization of mammalian neurofilament polypeptides within the neuronal cytoskeleton. J Cell Biol 1984;98:1523–1536.
Hisanaga S, Hirokawa N . Structure of the peripheral domains of neurofilaments revealed by low angle rotary shadowing. J Mol Biol 1988;202:297–305.
Sahlgren CM, Mikhailov A, Hellman J, et al. Mitotic reorganization of the intermediate filament protein nestin involves phosphorylation by cdc2 kinase. J Biol Chem 2001;276:16456–16463.
Sahlgren CM, Mikhailov A, Vaittinen S, et al. Cdk5 regulates the organization of nestin and its association with p35. Mol Cell Biol 2003;23:5090–5106.
Thomas SK, Messam CA, Spengler BA, et al. Nestin is a potential mediator of malignancy in human neuroblastoma cells. J Biol Chem 2004;279:27994–27999.
This study was supported in part by a grant from Interdisciplinary center of clinical investigation (IZKF) project A12 and the Deutsche Forschungsgememeinschaft (SFB 423, TP B6). Technical help of Ulrike Goller, Andrea Braun, Susanne Weber, Birgit Hausknecht and Tanja Christ is gratefully acknowledged. We are grateful to the Department of Pathology at the University Erlangen-Nuremberg (Erlangen, Germany) for providing human renal tissue samples. Portions of this work were presented at the American Society of Nephrology annual meeting, San Diego, November 12–17, 2003 (J Am Soc Nephrol, vol. 14, November 2003).
About this article
Cite this article
Daniel, C., Albrecht, H., Lüdke, A. et al. Nestin expression in repopulating mesangial cells promotes their proliferation. Lab Invest 88, 387–397 (2008). https://doi.org/10.1038/labinvest.2008.5
- stem cells
The diabetes drug semaglutide reduces infarct size, inflammation, and apoptosis, and normalizes neurogenesis in a rat model of stroke
Comparison of renal lesions in cats and dogs using pathomorphological and ımmunohistochemical methods
Biotechnic & Histochemistry (2019)
Shikonin‑mediated inhibition of nestin affects hypoxia‑induced proliferation of pulmonary artery smooth muscle cells
Molecular Medicine Reports (2018)
Nestin in the epididymis is expressed in vascular wall cells and is regulated during postnatal development and in case of testosterone deficiency
PLOS ONE (2018)
Glomeruli from patients with nephrin mutations show increased number of ciliated and poorly differentiated podocytes
Acta Histochemica (2018)